2014
DOI: 10.1007/s11419-014-0246-5
|View full text |Cite
|
Sign up to set email alerts
|

A case of death caused by abuse of a synthetic cannabinoid N-1-naphthalenyl-1-pentyl-1H-indole-3-carboxamide

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
32
0
1

Year Published

2014
2014
2020
2020

Publication Types

Select...
7
3

Relationship

0
10

Authors

Journals

citations
Cited by 28 publications
(33 citation statements)
references
References 10 publications
0
32
0
1
Order By: Relevance
“…Although the traditional marijuana and hashish containing D 9 -tetrahydrocannabinol as the psychoactive compound have been associated with almost no fatalities thus far, two reports have described fatalities caused by the synthetic cannabinoids MAM-2201 [10] and NNEI [11]. We also reported a fatal case due to the combined use of two synthetic cannabinoids, AB-CHMINACA and 5-fluoro-AMB, and the N-methyl-D-aspartate receptor channel blocker diphenidine [12].…”
Section: Introductionmentioning
confidence: 71%
“…Although the traditional marijuana and hashish containing D 9 -tetrahydrocannabinol as the psychoactive compound have been associated with almost no fatalities thus far, two reports have described fatalities caused by the synthetic cannabinoids MAM-2201 [10] and NNEI [11]. We also reported a fatal case due to the combined use of two synthetic cannabinoids, AB-CHMINACA and 5-fluoro-AMB, and the N-methyl-D-aspartate receptor channel blocker diphenidine [12].…”
Section: Introductionmentioning
confidence: 71%
“…Furthermore, the amount as well as the composition of synthetic cannabinoids has been found to vary for different herbal products (even those with the same brand name) [9]. These features may lead to unexpected, severe adverse symptoms including agitation, anxiety, paranoia, hallucination, psychosis, tachycardia, and seizures [10], and even a few fatal cases have been reported [11,12].…”
Section: Introductionmentioning
confidence: 99%
“…Moreover, there is always the possibility of external contamination from, for example, skin secretions, of passive contamination, and of removal of analyte through either excessive washing, or cosmetic hair treatment, or of distributing analyte from the surface to the matrix of hair during sample preparation [47]. As an ex-ample, studies have shown that synthetic cannabinoids, and indeed their metabolites, can be detected in hair segments seemingly dating from before the compounds in question were available on the drug market [48][49][50].…”
Section: Site Of Sample Collectionmentioning
confidence: 99%